Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Hypereosinophilic syndrome
ADR ID BADD_A04709
ADR Hierarchy
01      Blood and lymphatic system disorders
01.02      White blood cell disorders
01.02.04      Eosinophilic disorders
01.02.04.005      Hypereosinophilic syndrome
Description A heterogeneous group of disorders with the common feature of prolonged eosinophilia of unknown cause and associated organ system dysfunction, including the heart, central nervous system, kidneys, lungs, gastrointestinal tract, and skin. There is a massive increase in the number of EOSINOPHILS in the blood, mimicking leukemia, and extensive eosinophilic infiltration of the various organs. [MeSH]
MedDRA Code 10048643
MeSH ID D017681
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Hypereosinophilic syndrome | Hypereosinophilic Syndrome | Hypereosinophilic Syndromes | Syndrome, Hypereosinophilic | Syndromes, Hypereosinophilic | Leukemia, Eosinophilic | Eosinophilic Leukemia | Eosinophilic Leukemias | Leukemias, Eosinophilic | Loeffler's Endocarditis | Loefflers Endocarditis | Endocarditis, Loeffler's | Endocarditis, Loefflers | Loeffler Endocarditis | Endocarditis, Loeffler | Idiopathic Hypereosinophilic Syndrome | Hypereosinophilic Syndromes, Idiopathic | Idiopathic Hypereosinophilic Syndromes | Syndrome, Idiopathic Hypereosinophilic | Syndromes, Idiopathic Hypereosinophilic | Hypereosinophilic Syndrome, Idiopathic
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01136Imatinib0.000168%
BADD_D01393Meropenem0.000146%
BADD_D01610Omalizumab--
BADD_D01834Prednisone0.000009%
BADD_D01954Rivaroxaban0.000063%
BADD_D01971Rosuvastatin0.000034%
BADD_D02272Triamcinolone acetonide0.000041%
The 1th Page    1    Total 1 Pages